Table 3:
Results from Testing of the First Production Pathway
Release Criteria | Specification | Test 1A | Test 2A | Test 3A |
---|---|---|---|---|
Appearance | Clear, Colorless, No Particulates | Clear, Colorless, No Particulates | Clear, Colorless, No Particulates | Clear, Colorless, No Particulates |
Filter Integrity | > 40 psi | 51 psi | 52 psi | 52 psi |
pH | 4 – 8 | 4.5 | 4.5 | 4.5 |
Radiochemical Purity | ≥ 90% | > 99.9 % | 98.4 % | 99.2 % |
Molar Activity | ≥ 18.5 GBq/μmol (≥ 500 Ci/mmol) |
380 GBq/μmol (10282 Ci/mmol) |
415 GBq/μmol (11238 Ci/mmol) |
422 GBq/μmol (11403 Ci/mmol) |
Residual Solvent | ≤ 5000 ppm MEK | 0 ppm | 7.58 ppm | 6.84 ppm |
Formulation | NMT 10% EtOH | 7.8 % | 7.8 % | 7.2 % |
Total Chemical Impurities | NMT 50 μg/dose | 0.083 μg/mL | 0.240 μg/mL | 0.202 μg/mL |
Activity in Final Vial | 3.66 GBq (99.0 mCi) |
4.55 GBq (122.9 mCi) |
3.65 GBq (98.7 mCi) |
|
Concentration | 295 MBq/mL (7.97 mCi/mL) |
385 MBq/mL (10.4 mCi/mL) |
296 MBq/mL (8.0 mCi/mL) |